Rasna Therapeutics Inc (PK) (RASP) Fundamentals

Rasna Therapeutics, Inc. (OTC:RASP), a development stage biotechnology company focused on the development of cancer drugs, today announced the successful completion of its merger. Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the development of drug candidates for leukemia and lymphoma. Abnormal epigenetic modification is recognized to play an important role in the pathogenesis of acute myeloid leukemia (AML), leading to silencing of genes involved in tumor suppression and cellular reproduction. Rasna's focus on inhibition of lysine specific demethylase-1 (LSD1), an enzyme involved in epigenetic control, represents a promising and novel approach towards AML. Rasna has developed novel irreversible and reversible LSD1 regulators that have shown appropriate effects on the LSD1 gene in-vitro and in IND-enabling pre-clinical studies.
Share Info
Market Cap$ 2,195,748
Shares Authorized200,000,000
Shares Outstanding179,979,361
Shares Outstanding Date09/30/2022
Shareholder Count60
Shareholder Count Date03/31/2020
Float Date09/21/2022
Short Interest1,159
Short Interest Date01/14/2022
Reporting Info
Reporting StatusSEC Reporting
Audit StatusYes
AuditorMazars USA LLP
Auditor Address135 West 50th Street
New York, New York 10020
Auditor Websitehttp://mazarsusa.com/
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselSheppard, Mullin, Richter & Hampton LLP
Legal Counsel Address30 Rockefeller Center
New York, New York 10112-0015
Legal Counsel Websitehttp://www.sheppardmullin.com
Fiscal Year End9/30
ADR Ratio-
Transfer AgentPacific Stock Transfer Co.
Transfer Agent Address6725 Via Austi Parkway
Suite 300
Las Vegas, NV 89119
Depository Websitehttp://www.pacificstocktransfer.com
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:RASP
OTC Market TierPink Current
Security TypeCommon Stock
CIK Number0001582249
Address420 Lexington Avenue
Suite 2525
New York, New York 10170
Fax #-
SIC Code / Description2834 / Pharmaceutical preparations
Key ExecutivesController - Maria Preiss
CFO - Keeren Shah
Dir. - Gary Jacob
Dir. - John Brancaccio
Chairman - Willy Simon
Assistant to the CFO - Hana Malik
Number of Employees-
Incorporation StateNevada
Incorporation CountryUSA
Incorporation Year2012

Your Recent History
Rasna Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.